1. Introduction {#sec1}
===============

Alzheimer's disease (AD) is a neurodegenerative disease that seriously endangers the health of the elderly. Amyloid β protein (Aβ) plaque, as a "hallmark" of Alzheimer's disease, is believed to be closely related to the development of AD.^[@ref1]^ As the first positron-emission tomography (PET) agent targeting Aβ plaque, \[^18^F\]florbetapir ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}) was approved by Food and Drug Administration (FDA) for diagnosing AD in 2012.^[@ref2]^

![Structure of \[^18^F\]florbetapir.](ao0c01244_0001){#fig1}

Triethylene glycol (TEG)-substituted 4-(*N*-methyl-*N*-*Boc*-amino)styrylpyridine (**6**) was the key intermediate for \[^18^F\]florbetapir. The preparations of **6** had been reported in several literature.^[@ref3]−[@ref7]^ The styrylpyridine structure of **6** could be constructed by the Heck reaction^[@ref3],[@ref4]^ or Wittig--Horner reaction.^[@ref5],[@ref7]^ Kung et al.^[@ref4]^ reported a practical synthesis of **6** with 4-vinylaniline (**1**) and 2-bromo-5-iodopyridine/2-chloro-5-iodopyridine (**4a**/**4b**) as starting materials through the Heck reaction ([Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}). *tert*-Butyl methyl(4-vinylphenyl)carbamate (**3**) was a crucial intermediate to prepare **6**; however, **3** was difficult to obtain safely on a large scale due to the explosion hazards of sodium hydride (NaH) in *N,N*-dimethylformamide (DMF).^[@ref8]^ Other disadvantages, such as microwave reaction and repeated silica gel column chromatography separation, also limited the synthetic efficiency of **6**. An improved synthesis route reported by Benedum et al.^[@ref3]^ avoided using a microwave synthesizer and enabled a scale-up synthesis of **6**. However, the high prices of 4-vinylaniline and the palladium catalyst increased the cost of the target compound, and the explosion hazard of NaH/DMF was still a considerable potential danger in intermediate preparation.

![Published Synthesis of **6** by Kung and Colleagues^[@ref4]^](ao0c01244_0003){#sch1}

A new synthesis of **6** through the Wittig--Horner reaction was reported by Li et al. with (bromomethyl)-4-nitrobenzene (**7**) and 2-chloropyridine-5-carbaldehyde as starting materials^[@ref5]^ ([Scheme [2](#sch2){ref-type="scheme"}](#sch2){ref-type="scheme"}a). This synthesis route started from low-cost materials, but it required more steps and the smelly toxic reagent 4-methylbenzenethiol. A further improved preparation for **6** was disclosed by Yao and Li^[@ref7]^ ([Scheme [2](#sch2){ref-type="scheme"}](#sch2){ref-type="scheme"}b). Nonetheless, there were some drawbacks with respect to large-scale production: (1) the irritant starting material 4-bromobenzyl bromide (**13**), (2) reactions at a high temperature in a sealed tube, and (3) repeated purifications by silica gel column chromatography.

![Published Synthesis of **6** by (a) Li and Colleagues^[@ref5]^ and (b) Yao and Li^[@ref7]^](ao0c01244_0004){#sch2}

Without explosion hazards, harsh reaction conditions, or toxic reagents, another synthesis of **6** through the Wittig--Horner reaction reported by Benedum et al.^[@ref3]^ was more appropriate for scale-up preparation ([Scheme [3](#sch3){ref-type="scheme"}](#sch3){ref-type="scheme"}). However, the reductive stannous chloride/hydrogen chloride system in obtaining intermediate **17** was corrosive and less environmentally friendly; moreover, protection and deprotection on the hydroxyl group of TEG were made against the synthetic efficiency of **6**.

![Published Synthesis of **6** by Benedum and Colleagues^[@ref3]^](ao0c01244_0005){#sch3}

Herein, we report an improved synthesis of **6** with an overall yield of 26%. This new route starts with a cost-effective starting material 4-aminophenethyl alcohol, and **6** is obtained in five steps. It is worth noting that **22** was converted to **3** by a one-pot methylation and elimination in high yields. The main drawbacks in the previous research mentioned above have been avoided. The workup procedures are synthetic, efficient, and chromatographic purification-free, which is more suitable for large-scale preparation. Additionally, this paper provides comprehensive analytical and spectroscopic information for all compounds outlined in [Scheme [4](#sch4){ref-type="scheme"}](#sch4){ref-type="scheme"}.

![Optimized Synthesis Route of **6**](ao0c01244_0006){#sch4}

2. Results and Discussion {#sec2}
=========================

Although synthesizing **6** through the Heck reaction needed less steps and showed better synthetic efficiency than the Wittig--Horner reaction, the high cost of starting materials and the palladium catalyst was the main restriction for large-scale preparation. Since noble metal catalysts were indispensable for constructing C--C bonds in cross-coupling reactions, seeking for cheap raw materials became a feasible way to solve the problem. In the new strategy toward the synthesis of **6**, commercially available 4-aminophenethyl alcohol (**20**) (1 g/US\$ 3.39) was utilized as a cheaper starting material rather than 4-vinylaniline (1 g/US\$ 46.04). According to a known procedure,^[@ref9]^ 4-vinylaniline was prepared from **20** in two steps with an excellent yield by using excess NaOH; however, it would produce a large amount of waste bases. Subsequently, the preparation of **22** was optimized by using triethylamine (TEA). Then, crude **3** was obtained through one-pot methylation and elimination of **22** with methyl iodide and NaH in THF. Styrylpyridine was constructed with crude **3** via a Heck reaction catalyzed by palladium acetate, which was purified by recrystallization. Finally, **6** was obtained by introducing a TEG group in dioxane with *t*-BuOK as the base and purified by recrystallization. The overall yield of the five-step sequence shown in [Scheme [4](#sch4){ref-type="scheme"}](#sch4){ref-type="scheme"} was 25.94%, and the process was readily scalable and column chromatography-free.

2-(4-*tert*-Butoxycarbonylamino-phenyl)-ethyl *p*-toluenesulfonate (**22**) was the key intermediate for **3**. Our initial strategy to prepare **3** from **22** consisted of two reactions, β-elimination and then *N*-methylation. Generally, β-elimination of the tosyl group was carried out in THF with *t*-BuOK as the base to prepare Boc-protected vinylaniline (**2**).^[@ref10],[@ref11]^ However, as shown in [Scheme [5](#sch5){ref-type="scheme"}](#sch5){ref-type="scheme"}, the products were affected by the equivalent of *t*-BuOK. When 1--4 equiv of *t*-BuOK was screened, besides target compound **2**, a substituted byproduct dimer (**2a**) and trimer (**2b**) were also observed through intermolecular substitution; interestingly, 5 equiv of *t*-BuOK was required for a complete conversion from **22** to **2** for over 2 h. The optimization process is detailed in [Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}. Since the alkaline reaction condition of β-elimination was applicable to *N*-methylation in the next step, a "one-pot" synthesis process was conducted by adding methyl iodide into the reaction mixture to obtain target compound **3**. Disappointingly, the yield of **3** obtained was merely 8% by using 5 equiv of *t*-BuOK. We deemed that the steric hindrance of *t*-BuOK and the *tert*-butoxycarbonylamino group was detrimental to the deprotonation and further methylation on the nitrogen atom; residual tosilates in the reaction system also impacted the formation of nucleophilic anions. Employing Kung et al.'s conditions,^[@ref4]^ intermediate **3** was obtained after *N*-methylation with methyl iodide/NaH, which gave an 88% yield though separated steps. Additionally, the reaction solvent was replaced by THF from DMF in order to avoid explosion hazards.

![Elimination of **22** under *t*-BuOK Conditions](ao0c01244_0007){#sch5}

###### Optimization for Equivalent of *t-*BuOK

  entry   equivalent of *t*-BuOK   isolated yield[a](#t1fn1){ref-type="table-fn"}
  ------- ------------------------ ------------------------------------------------
  1       1                        **2** (5%), **2a** (70%), **2b** (25%)
  2       2                        **2** (13%), **2a** (50%), **2b** (37%)
  3       3                        **2** (17%), **2a** (46%), **2b** (37%)
  4       4                        **2** (30%), **2a** (30%), **2b** (40%)
  5       5                        **2** (82%), **2a** and **2b** (\<5%)

Isolated yields of compounds **2**, **2a**, and **2b** were calculated through column chromatography separations.

As described above, the nucleophilicity of the unmethylated *tert*-butoxycarbonylamino group in **22** was the main reason for these substituted dimerization and trimerization byproducts (**2a** and **2b**) in β-elimination. Hence, an alternative strategy wherein *N*-methylation proceeded ahead of β-elimination was proposed. Employing Kung et al.'s procedure,^[@ref4]^ the NaH/methyl iodide system was used for the *N*-methylation on the *tert*-butoxycarbonylamino group of **22**. Subsequently, in order to avoid the explosion hazards of NaH/DMF, several solvents (dioxane, 2-methyltetrahydrofuran, and THF) were screened to identify the optimal solvent with respect to security, reaction time, and yield. THF was identified to be the best choice regarding conversion time, yield, and cost. In consideration of the possibility that the deprotonated *tert*-butoxycarbonylamino group reacted with both the methyl iodide and tosylate group, it would form intermolecular-substituted byproducts. To reduce the possible side reactions, methyl iodide was dissolved in 300 mL of anhydrous THF, and 42 g of NaH was suspended in 1 L of anhydrous THF. NaH and excess methyl iodide were mixed under 0 °C, and then a solution of **22** in 200 mL of THF was added dropwise. In this condition, methyl iodide was kept excess, and the deprotonated amino group reacted with methyl iodide first.

Unexpectedly, besides target compound **24**, an iodo-byproduct *N*-Boc-*N*-methyl-4-(2-iodoethyl)phenylamine (**25**) and β-elimination product **3** were detected. We reasoned that the iodo-byproduct **25** was formed following the nucleophilic attack of iodide ion onto the tosyl group of **25**. In this case, the β-elimination of **25** became another alternative formation of **3**. Interestingly, the distribution of products was also affected by the equivalent of the base. As shown in [Scheme [6](#sch6){ref-type="scheme"}](#sch6){ref-type="scheme"}, 1--2 equiv of NaH mainly gave **24** and **25**. Compound **24** could be converted to **3** completely, while **25** could not be completely given to **3** when 3--4 equiv of NaH was added. When **22** was slowly added to 5 equiv of NaH in anhydrous THF, most of intermediate **25** was converted to **3** through β-elimination. The optimization process is detailed in [Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}. The molar ratio (NaH/**22** = 5:1) could be a key parameter to obtain **3** with a good yield of 93% in one-pot synthesis. A tentative proposal for the mechanism of **3** is sketched in [Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}.

![Possible formation mechanism of **3**.](ao0c01244_0002){#fig2}

![Elimination and Methylation of **22** in the NaH/CH~3~I System](ao0c01244_0008){#sch6}

###### Optimization for Equivalent of NaH in a One-Pot Reaction

  entry   equivalent of NaH   isolated yield[a](#t2fn1){ref-type="table-fn"}
  ------- ------------------- ------------------------------------------------
  1       1                   **3** (10%), **24** (60%), **25** (30%)
  2       2                   **3** (20%), **24** (40%), **25** (40%)
  3       3                   **3** (65%), **25** (35%)
  4       4                   **3** (87%), **25** (13%)
  5       5                   **3** (93%), **25** (7%)

Isolated yields of compounds **3**, **24**, and **25** were calculated through column chromatography separations.

The improved synthesis of **23** was performed according to the reported condition by Kung et al.^[@ref4]^ The main byproduct 6,6′-dibromo-3,3′-bipyridine (**23a**) was formed through palladium-catalyzed homocoupling of 2-bromo-5-iodopyridine ([Scheme [7](#sch7){ref-type="scheme"}](#sch7){ref-type="scheme"}). Additional **3** was employed to reduce the formation of **23a**, and molar ratios of **3** and 2-bromo-5-iodopyridine from 1 to 2.5 were screened ([Figure S1](http://pubs.acs.org/doi/suppl/10.1021/acsomega.0c01244/suppl_file/ao0c01244_si_001.pdf)). The influence of the reaction temperature was also studied, and different temperatures were screened from 45 to 110 °C ([Table S1](http://pubs.acs.org/doi/suppl/10.1021/acsomega.0c01244/suppl_file/ao0c01244_si_001.pdf)). The molar ratio and reaction temperature were fixed to be 1.5 and 65 °C, respectively, in the optimal condition, which could reduce the formation of **23a** along with an acceptable yield of **23**. It is worth noting that crude **3** was concentrated and used directly in this reaction.

![Heck Reaction and Byproduct](ao0c01244_0009){#sch7}

Microwave heating was avoided, and the reaction mixture of **23** and TEG was heated at 80 °C in the new route ([Table S2](http://pubs.acs.org/doi/suppl/10.1021/acsomega.0c01244/suppl_file/ao0c01244_si_001.pdf)). Finally, the reaction was accomplished in dioxane with *t*-BuOK as the base. Since the two hydroxyl groups in TEG had the same opportunity to react with **23**, the molar ratio of TEG and *t*-BuOK was 4:2.5 to prevent double-substituted byproducts of TEG. In the optimal condition, target compound **6** was obtained after recrystallization with a good yield of 70%.

3. Conclusions {#sec3}
==============

We developed an improved synthesis of TEG-substituted 4-(*N*-methyl-*N*-Boc-amino)styrylpyridine (**6**). This new route, using the cost-effective starting material 4-aminophenethyl alcohol, was done in five steps. The key intermediate **3** was prepared from **22** by a one-pot methylation/elimination with over 90% yields, and the explosion hazards were removed by using the NaH/THF reaction system. The main byproduct in the Heck reaction was confirmed, and it was affected by the equivalent amount of **3**. The subsequent reaction between **23** and TEG was completed in mild conditions without microwave heating. The workup procedures were synthetic efficient, and chromatographic purification-free. Compared to known methods, this approach shows several attractive merits, such as low-cost starting materials, mild reaction conditions, and simplified steps. The synthesis route showed the potential to achieve scaled-up preparation of **6** and established a preliminary foundation for the further research and applications of \[^18^F\]florbetapir toward AD.

4. Experimental Section {#sec4}
=======================

General procedures are as follows. All chemicals and solvents were reagent grade, and anhydrous solvents were obtained from an SG water solvent purification system. TLC analyses were conducted on silica gel plates (Sorbent Silica G UV254). Low-resolution mass spectral analyses were performed with a Waters 3100 mass spectrometer. ^1^H NMR and ^13^C NMR spectra were recorded on a Bruker AV400 spectrometer at 400 and 100 MHz, respectively. Chemical shifts (δ values) and coupling constants (*J* values) were given in ppm and hertz with tetramethylsilane as internal standards. The HPLC analyses were recorded by a standard method on a Shimadzu SPD-M20A HPLC instrument. The chemical purity was analyzed by using a Phenomenex Luna-C18 (5 μm, 4.60 mm × 250 mm) (30 °C, 1 mL/min, 278 nm, 20--30 min).

4.1. 4-(*tert-*Butoxycarbonylamino)Phenylethyl Alcohol (**21**) {#sec4.1}
---------------------------------------------------------------

4-Aminophenyl alcohol (120.9 g, 881.32 mmol, 1 equiv) was dissolved in 1300 mL of THF. Then, the solution of 4-aminophenyl alcohol was stirred at room temperature, and a solution of (Boc)~2~O (326.9 g, 1498 mmol, 1.7 eq) in 500 mL of THF was added dropwise. The reaction was monitored by TLC (petroleum ether/ethyl acetate = 3:1) and stirred overnight at room temperature. After reaction solution was concentrated to about 300 mL, a large amount of white solid was precipitated by adding 500 mL of *n*-hexane and then washed the precipitate with *n*-hexane (50 mL × 3). Then, 191.13 g of the white solid of **21** was obtained after drying. (91.39% yield, HPLC purity: 98.02%, melting point: 109.0--111.8 °C). ESI-MS *m*/*z* = 260.26 \[M + Na\]^+^~;~^1^H NMR (400 MHz, CDCl~3~) δ 7.30 (d, *J* = 8.4 Hz, 2H), 7.14 (d, *J* = 8.4 Hz, 2H), 6.47 (s, 1H), 3.82 (t, *J* = 6.4 Hz, 2H), 2.81 (t, *J* = 6.4 Hz, 2H), 1.51 (s, 9H); ^13^C NMR (100 MHz, CDCl~3~) δ 152.95, 136.78, 133.11, 129.54, 118.96, 80.49, 63.71, 38.48, 28.36.

4.2. 2-(4-*tert-*Butoxycarbonylamino-Phenyl)Ethyl *p*-Toluenesulfonate (**22**) {#sec4.2}
-------------------------------------------------------------------------------

Under a nitrogen atmosphere, triethylamine (40.90 g, 404.1 mmol, 2.2 equiv) and DMAP (2.24 g, 18.3 mmol, 0.1 equiv) were added to a solution of compound **21** (43.59 g, 183.7 mmol, 1 equiv) in DCM (400 mL), the mixture was cooled to 0--10 °C, and then TsCl (38.52 g, 201.967 mmol, 1.1 equiv) in DCM (200 mL) was added. The mixture was allowed to warm from 0 °C to room temperature for over 2 h, then the reaction was quenched with saturated aqueous NH~4~Cl. The organic layer was separated, and the aqueous phase was extracted with DCM (300 mL × 2). The combined organic layers were washed with brine and dried with anhydrous Na~2~SO~4~. The solution was evaporated under vacuum, and the resultant solids were recrystallized in isopropanol to yield **22** as a white crystalline solid (62.8 g, 87.33% yield, HPLC purity: 100.00%, melting point: 105.7--109.0 °C). ESI-MS *m*/*z* = 414.23 \[M + Na\]^+^; ^1^H NMR (400 MHz, CDCl~3~) δ 7.68 (d, *J* = 8.0 Hz, 2H), 7.28 (d, *J* = 8.0 Hz, 2H), 7.23 (d, *J* = 8.4 Hz, 2H), 7.02 (d, *J* = 8.8 Hz, 2H), 6.42 (s, 1H), 4.17 (t, *J* = 7.2 Hz, 2H), 2.89 (t, *J* = 7.2 Hz, 2H), 2.43 (s, 3H), 1.51 (s, 9H); ^13^C NMR (100 MHz, CDCl~3~) δ 152.74, 144.69, 137.20, 132.93, 130.74, 129.79, 129.43, 127.83, 118.70, 80.57, 70.73, 34.68, 28.35, 21.63.

4.3. *tert*-Butyl (4-Vinylphenyl)Carbamate (**2**) {#sec4.3}
--------------------------------------------------

Compound **22** (15 g, 38.32 mmol, 1.0 equiv) was added to a solution of *t-*BuOK (21.50 g, 191.60 mmol, 5 equiv) in anhydrous THF (250 mL) at 0 °C. The stirred reaction mixture was allowed to warm from 0 °C to room temperature for over 2 h. The reaction was then quenched with saturated aqueous NH~4~Cl, and the mixture was extracted with EA (200 mL × 2). The combined organic layers were washed with brine and dried with anhydrous Na~2~SO~4~. The solution was evaporated under vacuum, and the resultant solids were recrystallized in hexanes to yield **2** as a white crystalline solid (6.89 g, 82.02% yield, HPLC purity: 99.75%, melting point: 84.4--85.9 °C). ESI-MS *m*/*z* = 242.19 \[M + Na\]^+^; ^1^H NMR (400 MHz, CDCl~3~) δ 7.38--7.28 (m, 4H), 6.65 (dd, *J* = 17.6, 6.8 Hz, 1H), 6.47 (s, 1H), 5.65 (dd, *J* = 17.6, 0.8 Hz, 1H), 5.16 (dd, *J* = 10.8, 0.8 Hz, 1H), 1.52 (s, 9H); ^13^C NMR (100 MHz, CDCl~3~) δ 152.44, 137.75, 136.01, 132.33, 126.66, 118.22, 112.20, 80.42, 28.15.

4.4. *tert-*Butyl Methyl(4-Vinylphenyl)Carbamate (3) {#sec4.4}
----------------------------------------------------

Under a nitrogen atmosphere, CH~3~I (39.05 g, 272.5 mmol, 1.3 equiv) was dissolved in 300 mL of anhydrous THF, and NaH (42.00 g, 1.05 mol, 5 equiv) was suspended in 1 L of anhydrous THF. NaH and excess CH~3~I were mixed under 0 °C, and then a solution of **22** (82.05 g, 209.6 mmol, 1 equiv) in 200 mL of anhydrous THF was added dropwise. The mixture was cooled to 0--10 °C. The mixture was allowed to warm from 0 °C to room temperature for 4 h. The mixture was poured onto ice (500 g) extracted with EA (500 mL × 2). The combined organic phase was washed with brine (500 mL) and dried over anhydrous Na~2~SO~4~. After being concentrated in vacuum, the crude **3** was obtained, which was used directly for the next step without further purification. Purified **3** for analyses was colorless oil. ESI-MS *m*/*z* = 256.20 \[M + Na\]^+^; ^1^H NMR (400 MHz, CDCl~3~) δ 7.36 (d, *J* = 8.4 Hz, 2H), 7.19 (d, *J* = 8.4 Hz, 2H), 6.69 (dd, *J* = 17.6, 10.8 Hz, 1H), 5.71 (dd, *J* = 17.6, 0.8 Hz, 1H), 5.23 (dd, *J* = 10.8, 0.8 Hz, 1H), 3.26 (s, 3H), 1.45 (s, 9H); ^13^C NMR (100 MHz, CDCl~3~) δ 154.46, 143.12, 135.93, 134.41, 126.11, 125.15, 113.35, 80.15, 36.99, 28.13.

4.5. *tert*-Butyl (E)-(4-(2-(6-Bromopyridin-3-Yl)Vinyl)Phenyl)(Methyl)Carbamate (**23**) {#sec4.5}
----------------------------------------------------------------------------------------

Under a nitrogen atmosphere, a well-stirred mixture of crude **3** (44.01 g, 188.63 mmol, 1.5 equiv) from the last step, 2-bromo-5-iodopyridine (35.70 g, 125.75 mmol, 1 equiv), Pd(OAc)~2~ (4.23 g, 18.86 mmol, 0.15 equiv), TBAB (81.06 g, 251.5 mmol, 2 equiv), and K~2~CO~3~ (43.45 g, 314.38 mmol, 2.5 equiv) in DMF (700 mL) was heated at 65 °C for 3 h. The mixture was cooled to room temperature, and 500 mL of water was added. The mixture was extracted with EA (400 mL × 2). The EA-combined phase was washed with brine (500 mL), dried over anhydrous Na~2~SO~4~, and concentrated under reduced pressure to give the crude product. The crude product was recrystallized from hexanes/DCM (15:1) to give the pure product **23** as a white solid (27.66 g, 56.51% yield, HPLC purity: 96.07%, melting point: 118.1--120.4 °C). ESI-MS *m*/*z* = 389.20 \[M + H\]^+^, 411.22 \[M + Na\]^+^; ^1^H NMR (400 MHz, DMSO-d~6~) δ 8.58 (s, 1H), 8.02 (d, *J* = 8.4 Hz, 1H), 7.66 (d, *J* = 8.4 Hz, 1H), 7.59 (d, *J* = 8.0 Hz, 2H), 7.43 (d, *J* = 16.4 Hz, 1H), 7.32 (d, *J* = 8.0 Hz, 2H), 7.23 (d, *J* = 16.8 Hz, 1H), 3.20 (s, 3H), 1.41 (s, 9H); ^13^C NMR (100 MHz, DMSO-d~6~) δ 154.02, 149.18, 143.81, 140.07, 136.33, 133.62, 133.20, 131.24, 128.47, 127.27, 125.74, 123.61, 80.23, 37.24, 28.39.

4.6. TEG-Substituted 4-(*N*-Methyl-*N*-Boc-Amino)Styrylpyridine (**6**) {#sec4.6}
-----------------------------------------------------------------------

Under a nitrogen atmosphere, a stirred mixture of TEG (24.03 g, 160 mmol, 4 equiv) and *t*-BuOK (11.22 g, 100 mmol, 2.5 equiv) in anhydrous dioxane (260 mL) was heated to 65 °C for 0.5 h. Then, a solution of **23** (15.57 g, 40 mmol, 1 equiv) in anhydrous dioxane (80 mL) was added dropwise. The mixture was stirred for 2 h at 80 °C, and then the reaction was quenched with saturated aqueous NH~4~Cl. After the mixture was cooled with an ice bath, water (300 mL) was added slowly. The mixture was extracted with EA (200 mL × 2). The combined EA phase was washed with brine (200 mL), dried over anhydrous Na~2~SO~4~, and concentrated under reduced pressure to give the crude product. The crude product was recrystallized from hexanes/MTBE (5:1) to give the pure compound **6** as a yellowish solid (12.86 g, 70.12% yield, HPLC purity: 99.96%, melting point: 59.7--61.5 °C). ESI-MS *m*/*z* = 459.31 \[M + H\]^+^, 481.26 \[M + Na\]^+^; ^1^H NMR (400 MHz, CDCl~3~) δ 8.18 (s, 1H), 7.80 (d, *J* = 8.8 Hz, 1H), 7.44 (d, *J* = 8.0 Hz, 2H), 7.23 (d, *J* = 8.0 Hz, 2H), 6.97 (s, 2H), 6.81 (d, *J* = 8.8 Hz, 1H), 4.56--4.47 (m, 2H), 3.94--3.84 (m, 2H), 3.73 (m, 6H), 3.66--3.59 (m, 2H), 3.27 (s, 3H), 1.46 (s, 9H); ^13^C NMR (100 MHz, CDCl~3~) δ 162.79, 154.44, 145.41, 142.93, 135.17, 133.88, 127.09, 126.56, 126.22, 125.27, 124.23, 111.25, 80.24, 72.28, 70.46, 70.15, 69.51, 64.96, 61.55, 36.98, 28.13.

The Supporting Information is available free of charge at [https://pubs.acs.org/doi/10.1021/acsomega.0c01244](https://pubs.acs.org/doi/10.1021/acsomega.0c01244?goto=supporting-info).Experimental data, full ^1^H NMR, ^13^C NMR, MS spectra results, and HPLC data of key intermediates ([PDF](http://pubs.acs.org/doi/suppl/10.1021/acsomega.0c01244/suppl_file/ao0c01244_si_001.pdf))
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DCM

:   dichloromethane

DMAP

:   4-dimethylaminopyridine

EA

:   ethyl acetate

MTBE

:   methyl *tert*-butyl ether

*t*-BuOK

:   potassium *tert*-butanol

TEG

:   triethylene glycol

THF

:   tetrahydrofuran

TLC

:   thin layer chromatography
